Skip to content
10-K

Annual Report

KYMERA THERAPEUTICS, INC. KYMR

0001193125-26-073395

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 81.64M sh
Shares Diluted FY 2025 · Dec 31, 2025 84.49M sh
Shares Diluted FY 2025 · Dec 31, 2024 75.04M sh
Shares Diluted FY 2025 · Dec 31, 2023 58.37M sh
Capex FY 2025 · Dec 31, 2025 $1.45M
Capex FY 2025 · Dec 31, 2024 $12.84M
Capex FY 2025 · Dec 31, 2023 $34.48M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$232.89M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$194.5M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$102.83M
Cash And Equivalents FY 2025 · Dec 31, 2025 $357.01M
Cash And Equivalents FY 2025 · Dec 31, 2024 $120.26M
Cash And Equivalents FY 2025 · Dec 31, 2023 $109.97M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.58B
Stockholders Equity FY 2025 · Dec 31, 2024 $835.62M
Stockholders Equity FY 2025 · Dec 31, 2023 $394.97M
Stockholders Equity FY 2025 · Dec 31, 2022 $490.15M
Current Liabilities FY 2025 · Dec 31, 2025 $83.21M
Current Liabilities FY 2025 · Dec 31, 2024 $67.77M
Total Liabilities FY 2025 · Dec 31, 2025 $163.15M
Total Liabilities FY 2025 · Dec 31, 2024 $142.42M
Current Assets FY 2025 · Dec 31, 2025 $871.21M
Current Assets FY 2025 · Dec 31, 2024 $510.27M
Total Assets FY 2025 · Dec 31, 2025 $1.74B
Total Assets FY 2025 · Dec 31, 2024 $978.04M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.69
Eps Diluted FY 2025 · Dec 31, 2024 −$2.98
Eps Diluted FY 2025 · Dec 31, 2023 −$2.52
Eps Basic FY 2025 · Dec 31, 2025 −$3.69
Eps Basic FY 2025 · Dec 31, 2024 −$2.98
Eps Basic FY 2025 · Dec 31, 2023 −$2.52
Sga Expense FY 2025 · Dec 31, 2025 $68.19M
Sga Expense FY 2025 · Dec 31, 2024 $63.53M
Sga Expense FY 2025 · Dec 31, 2023 $55.04M
Rd Expense FY 2025 · Dec 31, 2025 $316.57M
Rd Expense FY 2025 · Dec 31, 2024 $240.25M
Rd Expense FY 2025 · Dec 31, 2023 $189.08M
Net Income FY 2025 · Dec 31, 2025 −$311.35M
Net Income FY 2025 · Dec 31, 2024 −$223.86M
Net Income FY 2025 · Dec 31, 2023 −$146.96M
Operating Income FY 2025 · Dec 31, 2025 −$349.4M
Operating Income FY 2025 · Dec 31, 2024 −$261.64M
Operating Income FY 2025 · Dec 31, 2023 −$165.53M
Cost Of Revenue FY 2025 · Dec 31, 2025 $39.21M
Cost Of Revenue FY 2025 · Dec 31, 2024 $47.07M
Cost Of Revenue FY 2025 · Dec 31, 2023 $78.59M
Revenue FY 2025 · Dec 31, 2025 $39.21M
Revenue FY 2025 · Dec 31, 2024 $47.07M
Revenue FY 2025 · Dec 31, 2023 $78.59M